Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberley Holt

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
American Journal of Respiratory and Critical Care Medicine|September 23, 2020
Aprepitant for Cough in Lung Cancer. A Randomized Placebo-controlled Trial and Mechanistic InsightsJaclyn A Smith, Amélie Harle, Rachel Dockry, et al.
The European Respiratory Journal|January 18, 2020
Gefapixant in two randomised dose-escalation studies in chronic coughJaclyn A Smith, Michael M Kitt, Peter Butera, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2017
XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory CoughMaria G Belvisi, Mark A Birrell, Michael A Wortley, et al.
American Journal of Respiratory and Critical Care Medicine|January 8, 2016
Neurophenotypes in Airway Diseases. Insights from Translational Cough StudiesMaria G Belvisi, Mark A Birrell, Saifudin Khalid, et al.
The European Respiratory Journal|November 6, 2025
Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomized, double-blind, parallel-group, placebo-controlled trialNermin Diab, Danica Brister, Elena Kum, et al.
ERJ Open Research|March 17, 2022
A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic coughHuda Badri, Carmen Gibbard, Dimitra Denton, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
American Journal of Respiratory and Critical Care Medicine|September 23, 2020
Aprepitant for Cough in Lung Cancer. A Randomized Placebo-controlled Trial and Mechanistic InsightsJaclyn A Smith, Amélie Harle, Rachel Dockry, et al.
The European Respiratory Journal|January 18, 2020
Gefapixant in two randomised dose-escalation studies in chronic coughJaclyn A Smith, Michael M Kitt, Peter Butera, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2017
XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory CoughMaria G Belvisi, Mark A Birrell, Michael A Wortley, et al.
American Journal of Respiratory and Critical Care Medicine|January 8, 2016
Neurophenotypes in Airway Diseases. Insights from Translational Cough StudiesMaria G Belvisi, Mark A Birrell, Saifudin Khalid, et al.
The European Respiratory Journal|November 6, 2025
Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomized, double-blind, parallel-group, placebo-controlled trialNermin Diab, Danica Brister, Elena Kum, et al.
ERJ Open Research|March 17, 2022
A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic coughHuda Badri, Carmen Gibbard, Dimitra Denton, et al.
Pageof 2